Skip to content
Disclosery

Provident Investment Management, Inc.: GSK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Provident Investment Management, Inc. on GSK, newest first. How the timeline and the estimate are built.

Provident Investment Management, Inc. held 0 GSK shares at 2025-06-30 per its 13F-HR filed 2025-08-26.

the latest 13F is the newest step

  1. period ended2025-06-30
    13F 0 shares
    Change vs previous 13F -21,750 shares

    13F-HR 0001420506-25-002458 filed by Provident Investment Management, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-03-31
    13F 21,750 shares
    Change vs previous 13F +75 shares

    0.08% of the 13F portfolio, value $842,595.

    13F-HR 0001420506-25-000972 filed by Provident Investment Management, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2024-12-31
    13F 21,675 shares
    Change vs previous 13F +3,100 shares

    0.07% of the 13F portfolio, value $733,049.

    13F-HR 0001420506-25-000316 filed by Provident Investment Management, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-09-30
    13F 18,575 shares
    Change vs previous 13F not available

    0.07% of the 13F portfolio, value $759,346.

    13F-HR 0001420506-24-002295 filed by Provident Investment Management, Inc.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).